ING Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Sell
1,900
-15,293
-89% -$4.23M ﹤0.01% 487
2026
Q1
$5.08M Sell
17,193
-267
-2% -$79.3K 0.03% 270
2025
Q4
$4.77M Sell
17,460
-232
-1% -$63K 0.03% 287
2025
Q3
$4.78M Sell
17,692
-552
-3% -$150K 0.03% 278
2025
Q2
$5.03M Sell
18,244
-18,736
-51% -$5.1M 0.03% 253
2025
Q1
$9.81M Sell
36,980
-122
-0.3% -$30.1K 0.07% 165
2024
Q4
$8.62M Sell
37,102
-1,863
-5% -$428K 0.06% 216
2024
Q3
$8.6M Sell
38,965
-26,386
-40% -$5.46M 0.05% 224
2024
Q2
$12.8M Sell
65,351
-855
-1% -$177K 0.08% 185
2024
Q1
$14.3M Buy
66,206
+45,416
+218% +$9.54M 0.1% 177
2023
Q4
$4.38M Sell
20,790
-163
-0.8% -$34.8K 0.04% 308
2023
Q3
$4.2M Sell
20,953
-10,721
-34% -$2.13M 0.04% 295
2023
Q2
$5.87M Buy
31,674
+13,831
+78% +$2.56M 0.04% 241
2023
Q1
$3.42M Sell
17,843
-328,735
-95% -$59.4M 0.03% 300
2022
Q4
$58.3M Buy
346,578
+229,428
+196% +$39.9M 0.58% 36
2022
Q3
$20.8M Buy
117,150
+28,666
+32% +$5.67M 0.35% 63
2022
Q2
$18.1M Buy
88,484
+4,231
+5% +$897K 0.21% 90
2022
Q1
$20M Buy
84,253
+17,313
+26% +$4.07M 0.2% 91
2021
Q4
$15.3M Buy
66,940
+16,694
+33% +$3.67M 0.14% 133
2021
Q3
$9.72M Buy
50,246
+658
+1% +$133K 0.12% 120
2021
Q2
$10.5M Buy
49,588
+4,335
+10% +$915K 0.17% 93
2021
Q1
$9.24M Sell
45,253
-1,400
-3% -$276K 0.19% 86
2020
Q4
$8.49M Buy
46,653
+13,641
+41% +$2.32M 0.19% 83
2020
Q3
$5.52M Buy
33,012
+5,339
+19% +$899K 0.23% 66
2020
Q2
$4.5M Sell
27,673
-3,221
-10% -$577K 0.19% 53
2020
Q1
$5.34M Sell
30,894
-25,519
-45% -$5.08M 0.23% 67
2019
Q4
$11.3M Buy
56,413
+2,232
+4% +$458K 0.34% 54
2019
Q3
$11.5M Buy
54,181
+22,009
+68% +$4.6M 0.29% 67
2019
Q2
$6.25M Sell
32,172
-23,547
-42% -$4.34M 0.11% 135
2019
Q1
$9.17M Sell
55,719
-11,520
-17% -$2.04M 0.2% 78
2018
Q4
$12.6M Buy
67,239
+19,962
+42% +$3.69M 0.27% 63
2018
Q3
$8.05M Buy
47,277
+14,444
+44% +$2.43M 0.14% 108
2018
Q2
$5.38M Sell
32,833
-14,717
-31% -$2.4M 0.1% 118
2018
Q1
$7.69M Buy
47,550
+4,423
+10% +$704K 0.14% 95
2017
Q4
$6.3M Sell
43,127
-2,020
-4% -$288K 0.11% 104
2017
Q3
$6.13M Buy
45,147
+11,989
+36% +$1.51M 0.12% 129
2017
Q2
$4.15M Buy
33,158
+44
+0.1% +$5.26K 0.08% 148
2017
Q1
$3.93M Sell
33,114
-12,191
-27% -$1.47M 0.07% 172
2016
Q4
$5.24M Buy
45,305
+11,716
+35% +$1.3M 0.1% 137
2016
Q3
$3.52M Buy
33,589
+13,873
+70% +$1.45M 0.04% 180
2016
Q2
$1.92M Buy
19,716
+12,814
+186% +$1.21M 0.03% 198
2016
Q1
$663K Sell
6,902
-5,024
-42% -$457K 0.01% 333
2015
Q4
$1.08M Buy
+11,926
New +$1.12M 0.01% 491
2015
Q3
Sell
-78,172
Closed -$7.27M 587
2015
Q2
$7.27M Sell
78,172
-23,249
-23% -$2.17M 0.04% 312
2015
Q1
$9.61M Sell
101,421
-14,605
-13% -$1.35M 0.05% 290
2014
Q4
$10.3M Buy
116,026
+6,530
+6% +$553K 0.05% 288
2014
Q3
$8.76M Buy
109,496
+9,352
+9% +$705K 0.05% 285
2014
Q2
$7.1M Buy
100,144
+37,936
+61% +$2.67M 0.04% 318
2014
Q1
$4.6M Sell
62,208
-14,676
-19% -$1.11M 0.02% 376
2013
Q4
$6.03M Sell
76,884
-30,960
-29% -$2.42M 0.03% 339
2013
Q3
$7.96M Buy
107,844
+35,344
+49% +$2.6M 0.04% 328
2013
Q2
$5.51M Buy
+72,500
New +$4.76M 0.03% 353

Other funds holding CME

ING Group's CME Position: Q2 2026 in Review

ING Group reduced its CME Group (CME) stake by 89% in Q2 2026, selling an estimated $4.23M and leaving 1,900 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #487.

ING Group first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $58.3M in Q4 2022. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • ING Group held 1,900 shares of CME Group worth $420K as of Q2 2026.
  • ING Group sold 15,293 CME Group shares in Q2 2026, an estimated $4.23M.
  • CME Group made up ﹤0.01% of ING Group's portfolio in Q2 2026, its #487 holding.
  • ING Group first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • ING Group's CME Group position peaked at $58.3M in Q4 2022.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.